---
title: "A Novel 2-Metagene signature to identify high-risk HNSCC patients amongst those who are clinically at intermediate risk and are treated with PORT."
collection: publications
permalink: https://www.mdpi.com/2072-6694/14/12/3031
excerpt: 'Developed a novel 2-metagene signature for risk stratification in head and neck squamous cell carcinoma (HNSCC) patients receiving postoperative radiotherapy, enabling personalized treatment decisions.'
date: 2022-06-20
venue: 'Cancers'
paperurl: 'https://www.mdpi.com/2072-6694/14/12/3031'
citation: 'Patil, S., et al. (2022). "A Novel 2-Metagene signature to identify high-risk HNSCC patients." <i>Cancers</i>, 14(12), 3031.'
doi: '10.3390/cancers14123031'
---
[Download paper here](https://www.mdpi.com/2072-6694/14/12/3031)